On Friday, Bolt Biotherapeutics Inc (NASDAQ: BOLT) opened higher 4.44% from the last session, before settling in for the closing price of $0.65. Price fluctuations for BOLT have ranged from $0.55 to $1.56 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 169.01%. Company’s average yearly earnings per share was noted 20.22% at the time writing. With a float of $25.81 million, this company’s outstanding shares have now reached $38.11 million.
The extent of productivity of a business whose workforce counts for 100 workers is very important to gauge. In terms of profitability, gross margin is 83.22%, operating margin of -663.38%, and the pretax margin is -592.57%.
Bolt Biotherapeutics Inc (BOLT) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Bolt Biotherapeutics Inc is 32.54%, while institutional ownership is 31.67%. The most recent insider transaction that took place on Dec 12 ’23, was worth 7,125. In this transaction Chief Financial Officer of this company bought 7,500 shares at a rate of $0.95, taking the stock ownership to the 36,272 shares. Before that another transaction happened on Dec 06 ’23, when Company’s Chief Financial Officer bought 2,500 for $0.78, making the entire transaction worth $1,955. This insider now owns 28,772 shares in total.
Bolt Biotherapeutics Inc (BOLT) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.43 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.5) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.22% per share during the next fiscal year.
Bolt Biotherapeutics Inc (NASDAQ: BOLT) Trading Performance Indicators
Check out the current performance indicators for Bolt Biotherapeutics Inc (BOLT). In the past quarter, the stock posted a quick ratio of 4.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.74, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.25 in one year’s time.
Technical Analysis of Bolt Biotherapeutics Inc (BOLT)
The latest stats from [Bolt Biotherapeutics Inc, BOLT] show that its last 5-days average volume of 0.24 million was superior to 0.17 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 64.64%. Additionally, its Average True Range was 0.04.
During the past 100 days, Bolt Biotherapeutics Inc’s (BOLT) raw stochastic average was set at 57.15%, which indicates a significant decrease from 67.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.46% in the past 14 days, which was higher than the 30.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6476, while its 200-day Moving Average is $0.9042. Now, the first resistance to watch is $0.7149. This is followed by the second major resistance level at $0.7504. The third major resistance level sits at $0.7829. If the price goes on to break the first support level at $0.6469, it is likely to go to the next support level at $0.6144. The third support level lies at $0.5789 if the price breaches the second support level.
Bolt Biotherapeutics Inc (NASDAQ: BOLT) Key Stats
There are currently 38,128K shares outstanding in the company with a market cap of 25.99 million. Presently, the company’s annual sales total 7,880 K according to its annual income of -69,200 K. Last quarter, the company’s sales amounted to 1,280 K and its income totaled -21,200 K.
